參考文獻(xiàn)/References:
[1] BRAIN W R,NORTHFIELD D,WILKINSON M.The neurological manifestations of cervical spondylosis[J].Brain,1952,75(2):187-225.
[2] NIU S,ANASTASIO A T,MAIDMAN S D,et al.The frequency of various“Myelopathic Symptoms”in cervical myelopathy:evaluation in a large surgical cohort[J].Clin Spine Surg,2020,33(10):E448-E453.
[3] LEE J H,LEE S H,SEO I S.The characteristics of gait disturbance and its relationship with posterior tibial somatosensory evoked potentials in patients with cervical myelopathy[J].Spine(Phila Pa 1976),2011,36(8):E524-E530.
[4] EBARA S,YONENOBU K,FUJIWARA K,et al.Myelopathy hand characterized by muscle wasting.A different type of myelopathy hand in patients with cervical spondylosis[J].Spine(Phila Pa 1976),1988,13(7):785-791.
[5] RHEE J M,HEFLIN J A,HAMASAKI T,et al.Prevalence of physical signs in cervical myelopathy:a prospective, controlled study[J].Spine(Phila Pa 1976),2009,34(9):890-895.
[6] YUE W M,TAN S B,TAN M H,et al.The Torg—Pavlov ratio in cervical spondylotic myelopathy:a comparative study between patients with cervical spondylotic myelopathy and a nonspondylotic,nonmyelopathic population[J].Spine(Phila Pa 1976),2001,26(16):1760-1764.
[7] KANG M S,LEE J W,ZHANG H Y,et al.Diagnosis of cervical OPLL in lateral radiograph and MRI:is it reliable?[J].Korean J Spine,2012,9(3):205-208.
[8] TETREAULT L A,DETTORI J R,WILSON J R,et al.Syste-matic review of magnetic resonance imaging characteristics that affect treatment decision making and predict clinical outcome in patients with cervical spondylotic myelopathy[J].Spine(Phila Pa 1976),2013,38(22 Suppl 1):S89-S110.
[9] TETREAULT L,KOPJAR B,NOURI A,et al.The modified Japanese Orthopaedic Association scale:establishing criteria for mild,moderate and severe impairment in patients with degenerative cervical myelopathy[J].Eur Spine J,2017,26(1):78-84.
[10] TETREAULT L,NOURI A,KOPJAR B,et al.The minimum clinically important difference of the modified Japanese Orthopaedic Association scale in patients with degenerative cervical myelopathy[J].Spine(Phila Pa 1976), 2015,40(21):1653-1659.
[11] 鄭筱萸.中藥新藥臨床研究指導(dǎo)原則(試行)[M].北京:中國醫(yī)藥科技出版社,2002:346.
[12] 國家中醫(yī)藥管理局.中醫(yī)病證診斷療效標(biāo)準(zhǔn)[M].南京:南京大學(xué)出版社,1994:189.
[13] 張成波,童正一,許金海,等.基于數(shù)據(jù)挖掘的中醫(yī)治療脊髓型頸椎病證治方藥規(guī)律研究[J].上海中醫(yī)藥雜志,2021,55(4):15-20.
[14] OSHIMA Y,SEICHI A,TAKESHITA K,et al.Natural course and prognostic factors in patients with mild cervical spondylotic myelopathy with increased signal intensity on T2-weighted magnetic resonance imaging[J].Spine(Phila Pa 1976),2012,37(22):1909-1913.
[15] SUMI M,MIYAMOTO H,SUZUKI T,et al.Prospective cohort study of mild cervical spondylotic myelopathy without surgical treatment[J].J Neurosurg Spine,2012,16(1):8-14.
[16] FEHLINGS M G,WILSON J R,KOPJAR B,et al.Efficacy and safety of surgical decompression in patients with cervical spondylotic myelopathy:results of the AO Spine North America prospective multi-center study[J].J Bone Joint Surg Am,2013,95(18):1651-1658.
[17] DEORA H,KIM S H,BEHARI S,et al.Anterior surgical techniques for cervical spondylotic myelopathy:WFNS spine committee recommendations[J].Neurospine,2019,16(3):408-420.
[18] LIU H,LI X,WANG J,et al.Comparison study of clinical outcomes and sagittal alignment improvement between an-terior and posterior fusion techniques for multilevel cervical spondylotic myelopathy[J].J Orthop Surg(Hong Kong),2021,29(1):2309499020988177.
[19] BAJAMAL A H,KIM S H,ARIFIANTO M R,et al.Posterior surgical techniques for cervical spondylotic myelopathy:WFNS spine committee recommendations[J].Neurospine,2019,16(3):403-407.
[20] AUDAT Z A,FAWAREH M D,RADYDEH A M,et al.Anterior versus posterior approach to treat cervical spondylotic myelopathy,clinical and radiological results with long period of follow-up[J].SAGE Open Med,2018,6:2050312118766199.
[21] BRAM R,FIORE S,LABIAK J J,et al.Combined anterior-posterior decompression and fusion for cervical spondylotic myelopathy[J].Am J Orthop(Belle Mead NJ),2017,46(2):E97-E104.
[22] MINAMIDE A,YOSHIDA M,SIMPSON A K,et al.Microendoscopic laminotomy versus conventional laminoplasty for cervical spondylotic myelopathy:5-year follow-up study[J].J Neurosurg Spine,2017,27(4):403-409.
[23] 王振亞,張浩浩,欒繼耀,等.補(bǔ)陽還五湯加減聯(lián)合電針治療38例脊髓型頸椎病臨床觀察[J].心血管外科雜志(電子版),2018,7(2):264.
[24] 吳弢,高翔,施杞,等.針灸配合地黃飲子加減方治療脊髓型頸椎病30例[J].上海針灸雜志,2004,23(3):12-13.
[25] 葉秀蘭,唐占英,莫文,等.復(fù)元活血湯合圣愈湯治療脊髓型頸椎病30例臨床觀察[J].江蘇中醫(yī)藥,2008,40(6):39-40.
[26] 趙東東.針灸治療脊髓型頸椎病的Meta分析[D].濟(jì)南:山東中醫(yī)藥大學(xué),2017.
[27] 朱成林,徐波,李艷,等.推拿治療脊髓型頸椎病的系統(tǒng)評價[J].陜西中醫(yī)藥大學(xué)學(xué)報,2016,39(2):71-74.
[28] 梁相強(qiáng),蘭曉飛,王韶康,等.脊髓型頸椎病術(shù)后殘留神經(jīng)癥狀的中醫(yī)藥治療研究進(jìn)展[J].中醫(yī)研究,2017,30(9):77-78.
[29] 楊峰,譚明生,移平,等.椎管減壓聯(lián)合中藥治療脊髓型頸椎病的臨床研究[J].中國骨傷,2018,31(1):30-36.
[30] 唐仲海.身痛逐瘀湯聯(lián)合ACCF治療脊髓型頸椎病的臨床觀察[D].蘭州:甘肅中醫(yī)藥大學(xué),2020.
[31] 阿吾提·卡斯木,侯宇龍,王旭凱.補(bǔ)陽還五湯對脊髓型頸椎病患者術(shù)后恢復(fù)影響的Meta分析[J].中醫(yī)學(xué)報,2022,37(7):1577-1582.
[32] 龍水文,李晉玉,鄭晨穎,等.脊髓型頸椎病術(shù)后脊髓神經(jīng)功能康復(fù)中醫(yī)治療研究進(jìn)展[J].中國中醫(yī)藥信息雜志,2021,28(7):137-140.
[33] 王冬,孫旗,賈育松,等.針刺治療頸椎后路椎管成形術(shù)后軸性癥狀的隨機(jī)對照研究[J].環(huán)球中醫(yī)藥,2019,12(9):1419-1421.
[34] 歐志亮.中藥熱奄包治療脊髓型頸椎病頸后路術(shù)后軸性癥狀的臨床療效觀察[D].福州:福建中醫(yī)藥大學(xué),2020.
[35] 路銀芝.電針穴位刺激治療對大鼠脊髓急性損傷運(yùn)動功能及神經(jīng)生長因子表達(dá)的影響[J].中國老年學(xué)雜志,2014,34(16):4620-4622.
[36] 王延之,劉栩豪,武志佳,等.杵針配合八段錦對脊髓型頸椎病術(shù)后軸性癥狀患者康復(fù)效果的影響[J].世界最新醫(yī)學(xué)信息文摘,2019,19(28):17-19.
[37] 覃波,邵晨蘭,趙衛(wèi)衛(wèi),等.改良太極“云手”對脊髓型頸椎病患者術(shù)后平衡功能以及彌散張量成像的影響[J].頸腰痛雜志,2020,41(6):661-665.
[38] 倪萍,時景璞.系統(tǒng)評價與Meta分析再評價方法的更新及展望[J].中國循證心血管醫(yī)學(xué)雜志,2018,10(10):1170-1174.
[39] JADAD A R,MOORE R A,CARROLL D,et al.Assessing the quality of reports of randomized clinical trials: is blinding necessary?[J].Control Clin Trials,1996,17(1):1-12.
[40] 曾憲濤,莊麗萍,楊宗國,等.Meta分析系列之七:非隨機(jī)實(shí)驗(yàn)性研究、診斷性試驗(yàn)及動物實(shí)驗(yàn)的質(zhì)量評價工具[J].中國循證心血管醫(yī)學(xué)雜志,2012,4(6):496-499.
[41] 陳薇,方賽男,劉建平.基于證據(jù)體的中醫(yī)藥臨床證據(jù)分級標(biāo)準(zhǔn)建議[J].中國中西醫(yī)結(jié)合雜志,2019,39(3):358-364.